Maxivision Eye Hospitals to Invest ₹400 Crore in Tamil Nadu Expansion.

Maxivision Super Speciality Eye Hospitals is set to invest approximately ₹400 crore in Tamil Nadu over the next 2-3 years, marking its entry into the state with a significant expansion plan. The investment includes ₹100 crore specifically for establishing a network of 10 super specialty eye hospitals and vision centers in Chennai alone.

Dr. GSK Velu, Chairman and Managing Director of Maxivision, stated that the company, which raised ₹1,300 crore from PE firm Quadria Capital in 2023, is planning to go for an IPO in 2027. He noted that Maxivision is currently the third-largest eye hospital chain in India by revenue, and the second-largest in terms of profit, with a current revenue of around ₹700 crore.

Velu explained the strategic timing of the expansion, saying, "For a city like Chennai, just one hospital will not be impactful. So we were waiting for adequate funding to cover Chennai city well with our network." He added that despite its size, the Chennai market is not yet saturated and offers significant opportunities for growth.

Founded in 1996 by Dr. Kasu Prasad Reddy and acquired by Dr. GSK Velu in 2011, Maxivision has previously focused its expansion efforts on Andhra Pradesh, Telangana, Gujarat, and Maharashtra since 2012.